Vitestro transform patient care with autonomous blood drawing technology.
Vitestro has raised $70.0M in total funding. The most recent round was Series B. The last funding was announced in March 2026.
Vitestro's investors include Invest-NL, Mayo Clinic, Sonder Capital, European Innovation Council, European Innovation Council Fund.
Vitestro is headquartered in Utrecht, The Netherlands.
Vitestro transform patient care with autonomous blood drawing technology.
Vitestro is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Vitestro — Funding & Investors." VCBacked, March 10, 2026, https://www.vcbacked.co/company/vitestro. Accessed July 20, 2026.
VCBacked. (2026). Vitestro — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/vitestro
{{cite web |title=Vitestro — Funding & Investors |url=https://www.vcbacked.co/company/vitestro |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated